Chi, Xiaojing
Zhang, Xinhui
Pan, Shengnan
Yu, Yanying
Shi, Yujin
Lin, Tianli
Duan, Huarui
Liu, Xiuying
Chen, Wenfang
Yang, Xuehua
Chen, Lan
Dong, Xiaoqian
Ren, Lili
Ding, Qiang
Wang, Jianwei
Yang, Wei
Funding for this research was provided by:
National Natural Science Foundation of China (81871667, 82002153)
Article History
Received: 25 December 2021
Revised: 26 January 2022
Accepted: 26 January 2022
First Online: 9 February 2022
Competing interests
: W.Y., X.C., X.L., X.Z., and H.D. have a pending patent application for the RBD-targeted nanobodies in this study.